ACCESS PACK EXPO XPRESS ONLINE TODAY
ACCESS PACK EXPO XPRESS ONLINE TODAY. Content is available on-demand through November 30th.
LEARN MORE

Quick Hits: Faulty Packaging Prompts Pfizer Recalls in UK

The drug’s packaging featured a flaw that lowered the dissolution rate of the API.

A recent FiercePharma article discussed the recall of Pfizer’s menopause drug, Duavee. The company voluntarily recalled two batches of the drug, which is marketed as Duavive abroad, over concerns of faulty packaging that might have reduced efficacy. A flaw in the drug’s foil laminate pouch allows oxygen to pass through, lowering the dissolution rate of the active pharmaceutical ingredient, bazedoxifene acetate.

This is just the latest in Pfizer’s ongoing troubles with the menopause drug. Just weeks ago, the company recalled 11 lots of the drug in the U.S., and two in Canada in late May. 

Access On-Demand Content Today
Discover innovative solutions for packaging and processing, automation, sustainability, e-commerce and more.
LEARN MORE
Access On-Demand Content Today
Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Unlock Learning Here
Discover Our Content Hub